311 related articles for article (PubMed ID: 9428982)
1. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
Yamano M; Kamato T; Miyata K
Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
[TBL] [Abstract][Full Text] [Related]
2. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
Miyata K; Yamano M; Kamato T; Akuzawa S
Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
[TBL] [Abstract][Full Text] [Related]
3. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
Linnik MD; Butler BT; Gaddis RR; Ahmed NK
J Pharmacol Exp Ther; 1991 Nov; 259(2):501-7. PubMed ID: 1941605
[TBL] [Abstract][Full Text] [Related]
4. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
5. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
de Ridder WJ; Schuurkes JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
[TBL] [Abstract][Full Text] [Related]
6. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
[TBL] [Abstract][Full Text] [Related]
7. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
8. 5-HT4 receptor mediated stimulation of gastric emptying in rats.
Hegde SS; Wong AG; Perry MR; Ku P; Moy TM; Loeb M; Eglen RM
Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):589-95. PubMed ID: 7675116
[TBL] [Abstract][Full Text] [Related]
9. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
Yamano M; Ito H; Kamato T; Miyata K
Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
[TBL] [Abstract][Full Text] [Related]
10. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
Ito C; Isobe Y; Tsuchida K; Higuchi S
Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
[TBL] [Abstract][Full Text] [Related]
12. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
[TBL] [Abstract][Full Text] [Related]
13. Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo.
Crema F; Modini C; Croci T; Langlois M; de Ponti F
J Pharmacol Exp Ther; 1999 Mar; 288(3):1045-52. PubMed ID: 10027842
[TBL] [Abstract][Full Text] [Related]
14. Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
Yamano M; Kamato T; Nagakura Y; Miyata K
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):145-50. PubMed ID: 9228202
[TBL] [Abstract][Full Text] [Related]
15. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the involvement of 5-HT4 receptors in the 5-hydroxytryptamine-induced pattern of migrating myoelectric complex in sheep.
Plaza MA; Arruebo MP; Murillo MD
Br J Pharmacol; 1997 Mar; 120(6):1144-50. PubMed ID: 9134228
[TBL] [Abstract][Full Text] [Related]
17. Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig.
Villalón CM; den Boer MO; Heiligers JP; Saxena PR
Br J Pharmacol; 1991 Jan; 102(1):107-12. PubMed ID: 2043916
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
Yoshida N; Omoya H; Kato S; Ito T
Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
[TBL] [Abstract][Full Text] [Related]
20. The mycotoxin, deoxynivalenol, delays gastric emptying through serotonin-3 receptors in rodents.
Fioramonti J; Dupuy C; Dupuy J; Bueno L
J Pharmacol Exp Ther; 1993 Sep; 266(3):1255-60. PubMed ID: 8371135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
